Cns Pharmaceuticals, Inc. · NASDAQ:CNSP
Levin Rami exercised options for 4,750 Cns Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 14, 2026 · Filed Aug 18, 2026
On Aug 14, 2026, Levin Rami (CEO and President) exercised options for 4,750 Cns Pharmaceuticals, Inc. shares, leaving 4,750 shares. Filed Aug 18, 2026 (Form 4).
- Options exercised
- 4,750 shares
- Holding after
- 4,750 shares
- Trading plan
- No
- Role
- CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock | Option exercise | 4,750 | 4,750 | Direct |
Source
Related
- Cns Pharmaceuticals, Inc.
- Levin Rami
- Cns Pharmaceuticals, Inc. shareholders
- Form 4 · Fisher Michal · Aug 18, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Form 4 · Charles Faith L. · May 20, 2026
- Schedule 13G/A · Stonepine Capital Management, LLC · May 15, 2026
- Schedule 13G · Ikarian Capital, LLC · Apr 17, 2026